2rf9: Difference between revisions
Jump to navigation
Jump to search
m Protected "2rf9" [edit=sysop:move=sysop] |
No edit summary |
||
Line 1: | Line 1: | ||
[[Image:2rf9.png|left|200px]] | [[Image:2rf9.png|left|200px]] | ||
{{STRUCTURE_2rf9| PDB=2rf9 | SCENE= }} | {{STRUCTURE_2rf9| PDB=2rf9 | SCENE= }} | ||
===Crystal structure of the complex between the EGFR kinase domain and a Mig6 peptide=== | ===Crystal structure of the complex between the EGFR kinase domain and a Mig6 peptide=== | ||
{{ABSTRACT_PUBMED_18046415}} | {{ABSTRACT_PUBMED_18046415}} | ||
Line 22: | Line 11: | ||
==See Also== | ==See Also== | ||
*[[Epidermal Growth Factor Receptor]] | *[[Epidermal Growth Factor Receptor|Epidermal Growth Factor Receptor]] | ||
==Reference== | ==Reference== | ||
<ref group="xtra">PMID: | <ref group="xtra">PMID:018046415</ref><references group="xtra"/> | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Receptor protein-tyrosine kinase]] | [[Category: Receptor protein-tyrosine kinase]] | ||
Line 34: | Line 23: | ||
[[Category: Pickin, K A.]] | [[Category: Pickin, K A.]] | ||
[[Category: Zhang, X.]] | [[Category: Zhang, X.]] | ||
[[Category: Anti-oncogene]] | [[Category: Anti-oncogene]] | ||
[[Category: Atp-binding]] | [[Category: Atp-binding]] | ||
[[Category: Cell cycle]] | [[Category: Cell cycle]] | ||
[[Category: Dimer]] | [[Category: Dimer]] | ||
[[Category: Disease mutation]] | [[Category: Disease mutation]] | ||
Line 46: | Line 33: | ||
[[Category: Membrane]] | [[Category: Membrane]] | ||
[[Category: Nucleotide-binding]] | [[Category: Nucleotide-binding]] | ||
[[Category: Phosphorylation]] | [[Category: Phosphorylation]] | ||
[[Category: Receptor]] | [[Category: Receptor]] | ||
[[Category: Secreted]] | [[Category: Secreted]] | ||
Line 54: | Line 39: | ||
[[Category: Transmembrane]] | [[Category: Transmembrane]] | ||
[[Category: Tyrosine-protein kinase]] | [[Category: Tyrosine-protein kinase]] | ||
Revision as of 13:15, 25 July 2012
Crystal structure of the complex between the EGFR kinase domain and a Mig6 peptideCrystal structure of the complex between the EGFR kinase domain and a Mig6 peptide
Template:ABSTRACT PUBMED 18046415
About this StructureAbout this Structure
2rf9 is a 4 chain structure of Epidermal Growth Factor Receptor with sequence from Homo sapiens. Full crystallographic information is available from OCA.
See AlsoSee Also
ReferenceReference
- ↑ Zhang X, Pickin KA, Bose R, Jura N, Cole PA, Kuriyan J. Inhibition of the EGF receptor by binding of MIG6 to an activating kinase domain interface. Nature. 2007 Nov 29;450(7170):741-4. PMID:18046415 doi:nature05998
Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)
OCACategories:
- Pages with broken file links
- Homo sapiens
- Receptor protein-tyrosine kinase
- Bose, R.
- Cole, P A.
- Jura, N.
- Kuriyan, J.
- Pickin, K A.
- Zhang, X.
- Anti-oncogene
- Atp-binding
- Cell cycle
- Dimer
- Disease mutation
- Glycoprotein
- Inhibition
- Kinase domain
- Membrane
- Nucleotide-binding
- Phosphorylation
- Receptor
- Secreted
- Transferase
- Transmembrane
- Tyrosine-protein kinase